Lung Injury in Vivax Malaria: Pathophysiological Evidence for Pulmonary Vascular Sequestration and Posttreatment Alveolar-capillary Inflammation

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2007 Jan 19

PMID 17230420

Citations 94

Authors

Nicholas M Anstey

Tjandra Handojo

Michael C F Pain

Enny Kenangalem

Emiliana Tjitra

Ric N Price

Graeme P Maguire

Affiliations

Soon will be listed here.

Abstract

Background: The mechanisms underlying lung injury in vivax malaria are not well understood. Inflammatory responses to Plasmodium falciparum and P. vivax, to our knowledge, have not previously been compared at an organ level.

Methods: Respiratory symptoms and physiological aspects were measured longitudinally in Indonesian adults with uncomplicated vivax (n=50) and falciparum (n=50) malaria. Normal values were derived from 109 control subjects. Gas transfer was partitioned into its alveolar-capillary membrane (D(M)) and pulmonary capillary vascular (V(C)) components, to characterize the site and timing of impaired gas transfer.

Results: Mean baseline V(C) volume was significantly reduced in vivax and falciparum malaria, improving with treatment in each species. Baseline D(M) function was not impaired in either species. The progressive deterioration in D(M) function after treatment was statistically significant in vivax malaria but not in uncomplicated falciparum malaria. Oxygen saturation deteriorated after treatment in vivax but improved in falciparum malaria.

Conclusions: The baseline reduction in V(C) volume but not in D(M) function suggests encroachment on V(C) volume by parasitized erythrocytes and suggests that P. vivax-infected erythrocytes may sequester within the pulmonary microvasculature. Progressive alveolar-capillary dysfunction after treatment of vivax malaria is consistent with a greater inflammatory response to a given parasite burden in P. vivax relative to that in P. falciparum.

Citing Articles

Plasmodium ovale Malaria in Travelers and Immigrants to the United States: A Case Series.

Mayhew J, Alali M, Enane L, Kirkpatrick L, John C Am J Trop Med Hyg. 2024; 112(1):66-71.

PMID: 39437774 PMC: 11720757. DOI: 10.4269/ajtmh.24-0333.

Malaria Presenting as TMA and Acute Cortical Necrosis: A Case Series.

Chakrabarti U, Chaturvedy M, Sabari B, Jhorawat R, Nalwa A, Bajpayee A Indian J Nephrol. 2024; 34(2):165-168.

PMID: 38681005 PMC: 11044689. DOI: 10.4103/ijn.ijn_206_23.

A fatal respiratory complication of malaria caused by Plasmodium vivax.

Lopez A, Martins E, Pina-Costa A, Pacheco-Silva A, Ferreira M, Mamani R Malar J. 2023; 22(1):303.

PMID: 37814260 PMC: 10563287. DOI: 10.1186/s12936-023-04720-1.

A systematic analysis of the human immune response to Plasmodium vivax.

Bach F, Munoz Sandoval D, Mazurczyk M, Themistocleous Y, Rawlinson T, Harding A J Clin Invest. 2023; 133(20).

PMID: 37616070 PMC: 10575735. DOI: 10.1172/JCI152463.

Culture and transfection: Two major bottlenecks in understanding biology.

Kumari S, Sinha A Front Microbiol. 2023; 14:1144453.

PMID: 37082177 PMC: 10110902. DOI: 10.3389/fmicb.2023.1144453.

References

Kochar D, Saxena V, Singh N, Kochar S, Kumar S, Das A . Plasmodium vivax malaria. Emerg Infect Dis. 2005; 11(1):132-4. PMC: 3294370. DOI: 10.3201/eid1101.040519. View

Curlin M, Barat L, Walsh D, Granger D . Noncardiogenic pulmonary edema during vivax malaria. Clin Infect Dis. 1999; 28(5):1166-7. DOI: 10.1086/517767. View

Hughes J, Bates D . Historical review: the carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell (Theta.Vc) components. Respir Physiol Neurobiol. 2003; 138(2-3):115-42. DOI: 10.1016/j.resp.2003.08.004. View

Price R, Tjitra E, Guerra C, Yeung S, White N, Anstey N . Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2008; 77(6 Suppl):79-87. PMC: 2653940. View

. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000; 94 Suppl 1:S1-90. View

Lomar A, Vidal J, Lomar F, Barbas C, de Matos G, Boulos M . Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz J Infect Dis. 2006; 9(5):425-30. DOI: 10.1590/s1413-86702005000500011. View

Puri S, Baker B, Dutka D, Oakley C, Hughes J, Cleland J . Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation. 1995; 91(11):2769-74. DOI: 10.1161/01.cir.91.11.2769. View

Hay S, Guerra C, Tatem A, Noor A, Snow R . The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004; 4(6):327-36. PMC: 3145123. DOI: 10.1016/S1473-3099(04)01043-6. View

Maguire G, Handojo T, Pain M, Kenangalem E, Price R, Tjitra E . Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia. J Infect Dis. 2005; 192(11):1966-74. PMC: 2566801. DOI: 10.1086/497697. View

10.

Steenhuis L, Groen H, Koeter G, van der Mark T . Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J. 2000; 16(2):276-81. DOI: 10.1034/j.1399-3003.2000.16b15.x. View

11.

Pukrittayakamee S, Chantra A, Vanijanonta S, White N . Pulmonary oedema in vivax malaria. Trans R Soc Trop Med Hyg. 1998; 92(4):421-2. DOI: 10.1016/s0035-9203(98)91075-6. View

12.

Bonay M, Bancal C, de Zuttere D, Arnoult F, Saumon G, Camus F . Normal pulmonary capillary blood volume in patients with chronic infiltrative lung disease and high pulmonary artery pressure. Chest. 2004; 126(5):1460-6. DOI: 10.1378/chest.126.5.1460. View

13.

Roughton F, Forster R . Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol. 1957; 11(2):290-302. DOI: 10.1152/jappl.1957.11.2.290. View

14.

Tanios M, Kogelman L, McGovern B, Hassoun P . Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit Care Med. 2001; 29(3):665-7. DOI: 10.1097/00003246-200103000-00037. View

15.

Karunaweera N, Grau G, Gamage P, Carter R, Mendis K . Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci U S A. 1992; 89(8):3200-3. PMC: 48833. DOI: 10.1073/pnas.89.8.3200. View

16.

James M . Pulmonary damage associated with falciparum malaria: a report of ten cases. Ann Trop Med Parasitol. 1985; 79(2):123-38. DOI: 10.1080/00034983.1985.11811899. View

17.

Handojo T, Anstey N, Kelly P, Pain M, Kenangalem E, Tjitra E . Normal spirometry, gas transfer and lung volume values in Papua, Indonesia. Southeast Asian J Trop Med Public Health. 2006; 37(3):571-7. View

18.

Robert C, Pouvelle B, Meyer P, Muanza K, Fujioka H, Aikawa M . Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells. Res Immunol. 1995; 146(6):383-93. DOI: 10.1016/0923-2494(96)81042-x. View

19.

Udomsanpetch R, Thanikkul K, Pukrittayakamee S, White N . Rosette formation by Plasmodium vivax. Trans R Soc Trop Med Hyg. 1995; 89(6):635-7. DOI: 10.1016/0035-9203(95)90422-0. View

20.

Lawn S, Krishna S, Jarvis J, Joet T, Macallan D . Case reports: pernicious complications of benign tertian malaria. Trans R Soc Trop Med Hyg. 2004; 97(5):551-3. DOI: 10.1016/s0035-9203(03)80024-x. View